December 1 2023 - GSK pulls ahead of Pfizer in RSV vaccine market as Arexvy nears blockbuster status

GSK pulls ahead of Pfizer in RSV vaccine market as Arexvy nears blockbuster status
Pfizer cans twice-daily oral obesity program
3 medtech spinoffs that reshaped the industry in 2023
FDA starts review of Padcev/Keytruda for bladder cancer
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud